SEC Form 4 · accession 0001104659-18-038713
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Micek
Director
Period of report
Mar 12, 2018
Accepted (ET)
Jun 6, 2018 · 9:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2,F3,F4 | $8.40 | Mar 12, 2018 | A | 38,643 | A | — | Aug 2, 2027 | Common Stock | 38,643 | 38,643 | D |
| Stock Option (right to buy)F1,F2,F5,F6 | $2.39 | Jun 1, 2018 | A | 146,804 | A | — | May 14, 2028 | Common Stock | 146,804 | 146,804 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan
- F2All share numbers and the exercise price reflect the 1-for-15 reverse stock split effected on June 1, 2018.
- F3The option grant was approved by the Issuer's board of directors on August 2, 2017, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on March 12, 2018.
- F4Vests in equal monthly installments, beginning August 2, 2017, such that it is vested in full on the 3-year anniversary of the grant date.
- F5The option grant was approved by the Issuer's board of directors on May 14, 2018, subject to the stockholders approving and effecting a reverse stock split. The Issuer's shareholders approved the reverse stock split on May 18, 2018 and effected such stock split on June 1, 2018.
- F6Vests in equal monthly installments, beginning on May 14, 2018, such that it is vested in full on the 3-year anniversary of the grant date.